Preliminary study on the profile of medication use and patient compliance in the treatment of systemic lupus erythematosus

Main Article Content

Sylvi Irawati
Adji Prayitno
Angel Angel
Rosati Herma Safitri

Abstract

This study aimed to describe medications used and compliance in systemic lupus erythematosus (SLE) patients. This was a nonexperimental and prospective study. Patients aged ≥18 years old, used medications for SLE and consented to participate were included in this study. Data was collected from September to November 2012 by observation and interview. Pill count method was used to measure patients compliance. All of 15 patients participated in this study were female with median of age 30 years old. Three patients received single medication and the rest received combination drugs. All patients used corticosteroids. In 12 patients it was combined with 1 or 2 of disease-modifying antirheumatic drugs (DMARDs). More than 50% patients did not comply with their medications. Further research is needed to elicit barriers for noncompliance and to produce strategy for improving the medication-taking-related behaviour in SLE patients.

Article Details

How to Cite
Irawati, S., Prayitno, A., Angel, A., & Safitri, R. H. (2015). Preliminary study on the profile of medication use and patient compliance in the treatment of systemic lupus erythematosus. Jurnal Sains Farmasi & Klinis, 2(1), 78–83. https://doi.org/10.29208/jsfk.2015.2.1.53
Section
Research Articles

References

Danchenko, N., Satia, J. A., & Anthony, M. S. (2006). Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus, 15(5), 308-318.

Isbagio, A., Albar, Z., Kasjmir, Y. I. (2006). Lupus eritematosus sistemik, dalam Sudoyo, AW., Setiyohadi, B., Alwi, I. (editors)., 2006. Buku ajar ilmu penyakit dalam. 4th edition, Departemen Ilmu Penyakit Dalam, Jakarta Pusat.

Bertsias, G. K., Ioannidis, J. P. A., Boletis, J., Bombardieri, S., Cervera, R., Dostal, C., ... & Isenberg, D. (2007). EULAR recommendations for the management of Systemic Lupus Erytematosus (SLE) Report of a Task Force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)*. Annals of the Rheumatic Diseases, 67, 195-205.

Koneru, S., Kocharla, L., Higgins, G. C., Ware, A., Passo, M. H., Farhey, Y. D., ... & Brunner, H. I. (2008). Adherence to medications in systemic lupus erythematosus. JCR: Journal of Clinical Rheumatology, 14(4), 195-201.

Daleboudt, G., Broadbent, E., McQueen, F., & Kaptein, A. A. (2011). Intentional and unintentional treatment nonadherence in patients with systemic lupus erythematosus. Arthritis care & research, 63(3), 342-350.

Jakes, R. W., Bae, S. C., Louthrenoo, W., Mok, C. C., Navarra, S. V., & Kwon, N. (2012). Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: Prevalence, incidence, clinical features, and mortality. Arthritis care & research, 64(2), 159-168.

Lockshin, M. D. (2007). Biology of the sex and age distribution of systemic lupus erythematosus. Arthritis Care & Research, 57(4), 608-611.

Costedoat-Chalumeau, N., Pouchot, J., Guettrot-Imbert, G., Le Guern, V., Leroux, G., Marra, D., ... & Piette, J. C. (2013). Adherence to treatment in systemic lupus erythematosus patients. Best Practice & Research Clinical Rheumatology, 27(3), 329-340.